Place · Level 3
Reproductive · Pregnancy
孕前 3 个月叶酸 · 神经管 21-28 天关闭 · 铁需求翻倍 · DHA 胎儿脑 · HPG 轴 + 更年期 + 男 T · 拆穿天然激素
Story path
- 1Pre-conception · 3-month windowPre-conception · 3-month window
- 2Neural tube · days 21–28Neural tube · days 21–28
- 3Pregnancy iron · doubledPregnancy iron · doubled
- 4DHA · fetal brainDHA · fetal brain
- 5Menopause + male TMenopause + male T
- 6Fertility · the timeline you don't seeFertility · the timeline you don't see
Chapter 1
Pre-conception · 3-month window
Pre-conception · 3-month window
The 3 months before conception is the highest-ROI nutritional window — the payoff far exceeds any mid- or late-pregnancy rescue. But Chinese-language internet discussion of this often gets diluted by marketing of 'pregnancy milk powder + DHA gummies + hyaluronic-acid drinks'.
The real evidence-based checklist (ACOG 2021 / WHO 2016 / China pre-pregnancy guidelines) breaks into three blocks.
Three things to do before the starting gun:
1. Women take 400-800 μg folate daily, starting 3 months before conception and continuing to gestational week 12. Women with prior NTD history, antiepileptic drug (AED) use, diabetes, or obesity should take the 4 mg high dose. Folate is the single strongest intervention for reducing neural-tube defects (NTD) — 50-70%.
2. Reach a reasonable BMI (18.5-23.9). BMI > 30 → 2-4× the risk of gestational diabetes, preeclampsia, macrosomia, C-section; BMI < 18.5 → preterm birth, low birth weight, fetal growth restriction. Paternal BMI also affects sperm quality and offspring metabolism (Salas-Huetos 2017).
3. Quit smoking, limit alcohol — both partners. Any level of alcohol during pregnancy can cause fetal alcohol spectrum disorder (FASD); WHO and AAP recommend both partners abstain for 3 months pre-conception. Smoking reduces placental blood flow, raising low birth weight and SIDS risk.
Pre-conception blood screening (ACOG 2021):
CBC — screen for iron-deficiency anemiathyroid-stimulating hormone: A pituitary hormone that prods the thyroid to work — it rises when the thyroid is underactive. — subclinical hypothyroidism affects embryonic neurodevelopment25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. — supplement if < 50 nmol/LVitamin B12 — required for vegans (low B12 + high folate is the 'folate trap')Rubella / varicella IgG — vaccinate before pregnancy if negativeHIV / syphilis / hepatitis BPeriodontitis screen (severe periodontitis is linked to preterm birth, B-tier evidence)
Chronic-disease stabilization matters far more than supplements:
Diabetes: HbA1c < 6.5%Hypertension: women on ACEi / ARB must switch (contraindicated in pregnancy)Hyperthyroidism / hypothyroidism: stabilize before conceptionDepression / anxiety medications: review safety with psychiatry
Getting the 3 months before conception right beats taking 20 supplements during mid-to-late pregnancy. This is one of the rare nutrition windows where early intervention compounds.
The real evidence-based checklist (ACOG 2021 / WHO 2016 / China pre-pregnancy guidelines) breaks into three blocks.
Three things to do before the starting gun:
1. Women take 400-800 μg folate daily, starting 3 months before conception and continuing to gestational week 12. Women with prior NTD history, antiepileptic drug (AED) use, diabetes, or obesity should take the 4 mg high dose. Folate is the single strongest intervention for reducing neural-tube defects (NTD) — 50-70%.
2. Reach a reasonable BMI (18.5-23.9). BMI > 30 → 2-4× the risk of gestational diabetes, preeclampsia, macrosomia, C-section; BMI < 18.5 → preterm birth, low birth weight, fetal growth restriction. Paternal BMI also affects sperm quality and offspring metabolism (Salas-Huetos 2017).
3. Quit smoking, limit alcohol — both partners. Any level of alcohol during pregnancy can cause fetal alcohol spectrum disorder (FASD); WHO and AAP recommend both partners abstain for 3 months pre-conception. Smoking reduces placental blood flow, raising low birth weight and SIDS risk.
Pre-conception blood screening (ACOG 2021):
CBC — screen for iron-deficiency anemiathyroid-stimulating hormone: A pituitary hormone that prods the thyroid to work — it rises when the thyroid is underactive. — subclinical hypothyroidism affects embryonic neurodevelopment25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. — supplement if < 50 nmol/LVitamin B12 — required for vegans (low B12 + high folate is the 'folate trap')Rubella / varicella IgG — vaccinate before pregnancy if negativeHIV / syphilis / hepatitis BPeriodontitis screen (severe periodontitis is linked to preterm birth, B-tier evidence)
Chronic-disease stabilization matters far more than supplements:
Diabetes: HbA1c < 6.5%Hypertension: women on ACEi / ARB must switch (contraindicated in pregnancy)Hyperthyroidism / hypothyroidism: stabilize before conceptionDepression / anxiety medications: review safety with psychiatry
Getting the 3 months before conception right beats taking 20 supplements during mid-to-late pregnancy. This is one of the rare nutrition windows where early intervention compounds.
Natural fertility supplements debunked
'Pre-conception preparation' is a highly commercialized lane; layering it by evidence makes the picture clearer.The few with real RCT evidence:
Folate 400-800 μg — NTD prevention (A-tier)Vitamin D ≥ 600 IU/day — in the deficient, improves birth weight and reduces preterm birth (B-tier)Iodine 150 μg/day (pre-conception) + 250 μg/day (pregnancy) — prevents fetal thyroid dysplasia and cognitive impairment (WHO strong recommendation)Iron-deficiency anemia treatment — supplement iron + co-administered vitamin C when Hb < 110 g/L (Hallberg 1989, WHO 2016)
Mixed evidence:
CoQ10 — for women 35+ and male sperm energetics; small RCTs show improved oocyte quality and sperm motility (Bentov 2014 and others), but sample sizes are small; not first-line, not a scamInositol (myo-inositol + D-chiro) — improves ovulation in PCOS / polycystic women (Teede 2023 PCOS guideline lists it as adjunct); no clear benefit in healthy womenOmega-3 (DHA + EPA) — 200 mg DHA/day during pregnancy is genuinely important for fetal brain; pre-conception evidence is weaker but reasonable
Weak or absent evidence (the majority):
'Pregnancy milk powder': mostly regular milk + DHA + folate; if your regular diet is balanced and you already take folate + calcium separately, this item is unnecessary'Royal jelly' / 'bird's nest': no RCT evidence; royal jelly's hormone-like compounds have triggered allergies — rare case reports of fatal anaphylaxis'Placenta extract' / 'deer-fetus syrup': no RCT data; some contain undeclared exogenous hormonesMale 'fertility' combos (arginine + maca + yohimbine): maca has weak evidence for sperm motility, but the effect is far smaller than quitting smoking, limiting alcohol, or losing weight
Both partners starting 6 months early with exercise, dietary improvement, smoking cessation, weight management, and periodontal treatment — that bundle's effect typically beats every supplement stacked together. This is the counter-intuitive truth in the nutrition story: earlier and more fundamental = more valuable.
Egg / oocyte timeline · fetal to menopause
Oocyte biology is the opposite of sperm biology — women are born carrying every egg they will ever have. This is the most counter-intuitive and most important fact in this scene.Full timeline:
Fetal week 20 is peak: ovaries contain 6-7 million primary oocytes, the most in a lifetime; from then on numbers only fall as atresia continues throughout lifeBirth: 1-2 million remain (80-90% already lost to atresia)Puberty (menarche): 300-500 thousand, entering cyclic consumptionReproductive years (12-45): each cycle activates 15-20 primordial follicles from the quiescent pool into a growing cohort, but only 1 ovulates (dominant follicle) — the other 14-19 die via atresia; 30 years adds up to ~400-500 ovulations plus 8,000-10,000 atretic lossesAge 35: 100-150 thousand left, decline visibly accelerates, chromosomal aneuploidy rates start to climb (age + meiotic error)Age 40: 20-30 thousand, aneuploidy ~50% (vs ~10% at 30), miscarriage rate sharply up, Down syndrome risk upMenopause (median 51): <1,000 (functional exhaustion); FSH surges, E2 collapses, perimenopausal symptoms appear
This curve tells us several things:
1. Eggs cannot regenerate. Male sperm are continuously produced from spermatogonial stem cells throughout life, but female oocytes have no reserve stem cell pool — one used, one gone. 'Ovarian age' isn't exactly chronological age but tracks it tightly on average.
2. 'Dormant' oocytes are actually frozen mid-meiosis I. Meiosis begins before birth and arrests at prophase I; the monthly 'activation' before ovulation finishes meiosis I and stops again at metaphase II; meiosis II only completes after fertilization. That decades-long pause is a window for DNA damage accumulation and is the chemical root of the high aneuploidy rates seen with maternal age.
3. AMH (Anti-Müllerian Hormone) is the marker of ovarian reserve. Secreted by granulosa cells of small preantral follicles, it reflects how much 'reserve army' remains; unlike FSH, AMH doesn't fluctuate across the cycle and can be measured any day. Reading: in women 20-30, <1.0 ng/mL signals low reserve and deserves attention; 1.0-3.5 ng/mL is normal; >3.5 ng/mL suggests possible PCOS. AMH doesn't directly predict natural conception, but it does predict IVF stimulation response.
4. Oocyte quality matters more than count. Past 35 the issue is rarely 'no eggs left' — it's that the remaining eggs have high aneuploidy rates. Interventions with some RCT signal for quality:
CoQ10 200-600 mg/day — Bentov 2014 and other small trials, mitochondrial functionDHEA 25-75 mg/day — used at some IVF centers (controversial, only in older or diminished-ovarian-reserve (DOR) patients)Inositol — PCOS patientsAdequate vitamin DLimit alcohol, quit smoking, weight management, antioxidant-rich diet (Mediterranean)
5. Egg freezing — the real numbers:
Freeze 15-20 eggs before 35: live-birth rate per round 70-90%Freeze 15-20 at 38: 50-60%Freeze at 40+: 30-40%, more eggs doesn't lift it muchVitrification technology since the 2010s gives ≥90% post-thaw survival — that's no longer the bottleneck
The point: age determines quality; more eggs frozen doesn't fix age.
'Ovarian maintenance' debunked:
'Ovary massage' has no evidence base, and some techniques may damage tissue'Beauty-salon ovarian maintenance' is a commercial gimmick with no medical evidence'Placenta extract / royal jelly / TCM tonics' mostly do nothing, and some contain undeclared hormonesWhat you can actually do: quit smoking, limit alcohol, weight management (PCOS), treat chronic disease, sleep adequately, reduce chemical exposure (BPA, phthalates)
Clinical red flags to take seriously:
Acute pelvic pain that is severe and persistent, with vomiting or syncope, may be ovarian torsion — go to the ER immediatelyEctopic pregnancy: missed period + unilateral abdominal pain + vaginal bleeding + shoulder-tip pain or syncope — also an ER visit; this is one of the avoidable causes of death in women of reproductive age
Atlas reading: menstrual-cycle (HPO + cycle mechanism), perimenopause (E2 withdrawal, KNDy, MHT), PCOS, plus the fertility assessment (AMH) in the report engine.
Sperm timeline · production + WHO params
The sperm story is the opposite of the egg story: men make sperm continuously through life, but quality and quantity quietly decline.Spermatogenesis (an under-taught part of the Atlas):
Spermatogonial stem cells sit at the base of the seminiferous tubules and divide / differentiate throughout lifePathway: type A spermatogonia → type B spermatogonia → primary spermatocyte → meiosis I → secondary spermatocyte → meiosis II → spermatid → spermatozoonFull cycle ~74 days (spermatogonium to mature sperm), then ~12 days in the epididymis to acquire motility and fertilization competenceTotal ~90 days (3 months) — this is why preconception lifestyle changes need a 3-month lead time to show up
Normal fertility parameters (WHO 2010 / 2021):
| Parameter | Lower reference limit |
|---|---|
| Semen volume | ≥ 1.5 mL |
| Total sperm count | ≥ 39 × 10⁶/ejaculate |
| Sperm concentration | ≥ 15 × 10⁶/mL |
| Total motility (PR + NP) | ≥ 40% |
| Progressive motility (PR) | ≥ 32% |
| Normal morphology | ≥ 4% (strict Kruger criteria) |
| Viability | ≥ 58% |
| pH | 7.2-8.0 |
A few notes:
'Normal' is not 'optimal' — a man whose parameters just clear the lower limits can still struggle with natural conception'Normal morphology 4%' sounds low because the 1999 shift to strict Kruger criteria reset the bar — 4% is where most fertile men actually sitSemen analysis has intrinsic variability + sampling effects — do it at least twice, 2-4 weeks apart, and average
Global decline + age + external causes
The global sperm-decline trend (Levine 2017 / 2022 meta):Western male sperm concentration fell 51% between 1973 and 2018 (from ~100 M/mL to ~49 M/mL)Total sperm count fell 62% over the same windowThe decline is accelerating — steeper after 1990Chinese data (Huang 2017 PNAS) point the same directionLikely drivers: endocrine disruptors (BPA, phthalates), obesity, sedentariness, heat, ultra-processed food
This is one of the largest hidden concerns in global reproductive health.
Male fertility decline with age:
From 35+, sperm DNA fragmentation (DFI) risesFrom 40+, count and motility drift down gentlyFrom 45+, de novo mutation rate rises, and paternal age >45 is mildly associated with autism + schizophrenia risk in offspringA 70-year-old man can still father children — the curve is far flatter than the female curve
Main external causes of sperm damage:
1. Heat: testes need to sit 2-3°C below core temperature; sedentary work, tight underwear, laptop-on-lap, repeated saunas or hot baths raise local temperature and depress production — fix those and parameters recover over ~3 months
2. Smoking: DNA fragmentation up, morphology worse, concentration down; quitting for 3-6 months produces clear improvement
3. Heavy alcohol: suppresses testicular Leydig cells → T down, plus direct toxicity to sperm; limit to ≤7 units/week as a baseline
4. Obesity (BMI > 30): Salas-Huetos 2017 meta shows BMI strongly negatively correlated with sperm parameters; mechanism is fat-tissue aromatization of androgens → E2 ↑ → HPG axis suppressed, plus local testicular heat; even 5-10% weight loss visibly improves parameters
5. Endocrine-disrupting chemicals (EDCs): BPA in plastic bottles, can liners, thermal-receipt paper; phthalates in soft plastics, cosmetics, fragrance; PFAS ('forever chemicals') in non-stick cookware, water-resistant clothing, food packaging; pesticides (glyphosate, organophosphates, pyrethroids) in food residue. Practical: limit plastic, glass food storage, fewer non-stick pans, more organic produce, less processed food
6. Chronic disease: diabetes and hypertension directly and via meds; hypo- or hyperthyroidism via HPG axis; depression and chronic stress via hypothalamic–pituitary–adrenal axis: The body's stress-response chain (hypothalamus → pituitary → adrenal) that releases cortisol. suppressing HPG; OSA via hypoxia and lower T; treating the disease partially restores fertility
Interventions by RCT tier + cryopreservation
Sperm-quality interventions, by RCT strength:A (strong): quit smoking, weight loss (in obese), moderate (not extreme) exercise, limit alcoholB (moderate): antioxidant cocktails (vit C + E + Zn + Se + CoQ10 + L-carnitine) — Cochrane 2019 review shows partial benefit; omega-3; adequate vitamin DC (weak / mostly commercial): maca with small positive trials, effect much smaller than lifestyle; D-aspartic acid weak signal; ashwagandha with positive small trials (Ambiye 2013); 'male vitality / spermatogenesis' combo formulas heavily marketed, evidence thin
Sperm banking / cryopreservation:
Before chemo or radiation: bank aheadDelaying fatherhood (35+): an option, but since sperm production is continuous, banking isn't as necessary as egg freezingSurvival: modern cryopreservation 60-80%
Atlas reading: andropause (T + LOH), endocrine, microplastics (EDC exposure), alcohol-metabolism, obesity / metabolic-syndrome, ashwagandha (commercial vs evidence).
Chapter 2
Neural tube · days 21–28
Neural tube · days 21–28
One of the most critical windows in embryonic development is days 21-28 post-fertilization — the time of neural-tube closure. Most women don't yet know they're pregnant at this point, which is the chemical reason behind the rule 'start folate 3 months before'.
The embryology of neural-tube closure:
Days 17-19 post-fertilization: the neural plate forms in the ectodermDays 20-22: the neural plate folds upward into a groove (neural groove)Days 23-26: the groove's edges zip together from the middle outwardBy day 28: closure should be complete, forming the neural tube — the future brain + spinal cord
When folate is insufficient, closure fails, producing neural-tube defects (NTDs):
Anencephaly: failure of cephalic closure; the fetus has no cerebral hemispheres — most are stillborn or die as newbornsSpina bifida: failure of caudal closure; varying degrees of neural damage, with severe cases causing lower-limb paralysis and bowel / bladder incontinenceEncephalocele: skull defect with herniation of brain tissue
Folate's prevention of NTDs is one of modern medicine's strongest public-health wins:
MRC 1991 *Lancet* RCT: in women with prior NTD pregnancies, 4 mg/day folate cut recurrence by 72%Czeizel 1992 *NEJM* RCT: in the general population, 0.8 mg/day reduced first-occurrence NTD to zero (no cases in intervention group, multiple in control)Mechanism: folate → one-carbon metabolism → purine + thymidine synthesis → meets the rapid proliferation rate of neural-tube cells; partly via methylation + homocysteine pathway (see folate / one-carbon L4)
Global public-health progress:
The US has mandated 0.14 mg folate per 100 g of flour since 1998; NTD incidence fell from 1/2,000 to 1/3,000-4,000 (Williams 2015 *MMWR*)80+ countries have mandatory folate fortification: Canada, Chile, Costa Rica, Australia, etc.Most European countries fortify voluntarily, NTD incidence hasn't fallen meaningfully, and policy debate continuesChina has provided free folate (0.4 mg/day) to women of reproductive age since 2009; rural NTD has dropped significantly but urban-rural gaps remain
Click 'Take a closer look' for a 4-step animation of neural-tube closure days 17-28 and the chemical roots of closure failure under folate insufficiency.
The embryology of neural-tube closure:
Days 17-19 post-fertilization: the neural plate forms in the ectodermDays 20-22: the neural plate folds upward into a groove (neural groove)Days 23-26: the groove's edges zip together from the middle outwardBy day 28: closure should be complete, forming the neural tube — the future brain + spinal cord
When folate is insufficient, closure fails, producing neural-tube defects (NTDs):
Anencephaly: failure of cephalic closure; the fetus has no cerebral hemispheres — most are stillborn or die as newbornsSpina bifida: failure of caudal closure; varying degrees of neural damage, with severe cases causing lower-limb paralysis and bowel / bladder incontinenceEncephalocele: skull defect with herniation of brain tissue
Folate's prevention of NTDs is one of modern medicine's strongest public-health wins:
MRC 1991 *Lancet* RCT: in women with prior NTD pregnancies, 4 mg/day folate cut recurrence by 72%Czeizel 1992 *NEJM* RCT: in the general population, 0.8 mg/day reduced first-occurrence NTD to zero (no cases in intervention group, multiple in control)Mechanism: folate → one-carbon metabolism → purine + thymidine synthesis → meets the rapid proliferation rate of neural-tube cells; partly via methylation + homocysteine pathway (see folate / one-carbon L4)
Global public-health progress:
The US has mandated 0.14 mg folate per 100 g of flour since 1998; NTD incidence fell from 1/2,000 to 1/3,000-4,000 (Williams 2015 *MMWR*)80+ countries have mandatory folate fortification: Canada, Chile, Costa Rica, Australia, etc.Most European countries fortify voluntarily, NTD incidence hasn't fallen meaningfully, and policy debate continuesChina has provided free folate (0.4 mg/day) to women of reproductive age since 2009; rural NTD has dropped significantly but urban-rural gaps remain
Click 'Take a closer look' for a 4-step animation of neural-tube closure days 17-28 and the chemical roots of closure failure under folate insufficiency.
Folate trap, MTHFR, controversies
The folate story is more complex than the public realizes; a few common controversies need unpacking.Controversy 1: the folate trap
Large unmetabolized folic acid (UMFA) accumulating in plasma at high doses is a real phenomenon, but the clinical consequence evidence is mixedThe real concern is 'masking B12 deficiency': folate corrects megaloblastic anemia, but neurological damage continues to progress — eventually irreversiblySolution: vegans, the elderly, and people with low gastric acid must check B12 alongside folate
Controversy 2: MTHFR gene testing
The MTHFR C677T polymorphism reduces enzyme activity by 30-50% (the TT homozygote frequency in Han Chinese is ~30-40%, higher than in Caucasians)The commercial line 'MTHFR test → must take 5-MTHF (active folate)' is over-extensionReality: standard 400 μg folic acid still prevents NTDs in TT individuals — adequate quantity is what matters5-MTHF (Quatrefolic / Metafolin) costs 2-3× more, with marginal added clinical benefit; combining it with TMG (see tmg-betaine story) is a reasonable scenario
Controversy 3: 'folate overload' from fortified foods
Concern: in the US, exposure from fortified staples + personal supplements may exceed 1 mg/dayOne concern: masking B12 deficiency in the elderly — CDC and IOM are monitoringAnother: relation to colon or prostate cancer — large cohorts show no clear effect, but it's an active research areaConsensus: for women of reproductive age, benefit far exceeds potential risk; fortification policy has been stable for 30+ years
Operational summary:
All women trying to conceive / in early pregnancy: 0.4-0.8 mg/day folate; a multivitamin containing B12 + B6 is a reasonable choicePrior NTD history, antiepileptic drugs (especially valproate), diabetes, obesity, strong MTHFR suspicion: 4 mg/dayMen also supplementing folate has evidence for improving sperm DNA integrity (Salas-Huetos 2017)Don't agonize over 'natural vs synthetic' — synthetic folic acid has the strongest NTD-prevention RCT evidence; dietary folate (5-MTHF) is just as good, but hitting 400-800 μg from food alone is hard
Chapter 3
Pregnancy iron · doubled
Pregnancy iron · doubled
Pregnancy is the stage of life with the highest iron requirement in healthy adult women — mid-to-late pregnancy EAR rises from ~18 mg/day to ~27 mg/day (China DRI), double that of non-pregnant women and 4× that of same-age men.
The spike comes from five pulls on iron:
1. Fetal iron storage: a full-term newborn has ~270-300 mg of iron stored in the liver to support the 4-6 months until solid foods begin — all of it from the mother
2. Placenta + umbilical cord: ~90 mg of iron
3. Maternal blood volume rises 45-50%: red cell mass also increases, but plasma rises more, producing 'physiological dilution'
4. Delivery blood loss: ~500 mL for vaginal delivery, ~1,000 mL for C-section
5. Lactation: breast milk is low in iron (~0.3 mg/L), but lactation delays return of menses, cutting period blood loss
WHO 2016 recommendations:
Routine 30-60 mg/day iron + 0.4 mg/day folate throughout pregnancyIron-deficient regions or anemia-endemic areas: daily supplementationIron-adequate or screening-normal regions: intermittent supplementation (3×/week) is also effective
The cost of pregnancy iron-deficiency anemia:
Maternal: fatigue, elevated risk of intrapartum and postpartum hemorrhageFetal: preterm birth, low birth weight, cognitive delay in infancy (iron is critical for infant myelination; long-term IQ averages 1-2 points lower — irreversible)The reverse is also a problem: maternal over-iron (Hb > 130 g/L) is linked to fetal growth restriction — not 'more is better'
Practical pitfalls of iron supplementation:
Form: ferrous sulfate / fumarate (Fe²⁺) > ferrous gluconate; polysaccharide-iron complexes are weaker; newer ferric maltol has fewer side effectsEmpty stomach gives the best absorption but more GI irritation; alternate-day dosing (Stoffel 2017) gives higher total absorption in healthy mildly-deficient individuals because daily dosing suppresses hepcidin (see iron / gut L4), and alternate days let hepcidin resetCo-administer with vitamin C: 50-100 mg vitamin C increases non-heme iron absorption 2-4× (see vitamin-c / iron L4)Avoid simultaneous calcium, tea, coffee, milk, or antacids — separate by at least 2 hoursSide effects: constipation, dark stools, GI upset; can halve the dose, switch forms, or, for persistent issues, consider IV ironSevere deficiency (Hb < 90 g/L) is hard to correct orally; usually directly treated with IV iron (ferric carboxymaltose)
On 'pregnancy tea / bird's nest / Ejiao for blood': Ejiao is traditionally said in TCM to 'tonify blood', but its actual iron content is very low (~0.2 mg/g dry); from a modern perspective, pork liver, beef, clams, and fortified grains contain 10-100× more iron than Ejiao.
The spike comes from five pulls on iron:
1. Fetal iron storage: a full-term newborn has ~270-300 mg of iron stored in the liver to support the 4-6 months until solid foods begin — all of it from the mother
2. Placenta + umbilical cord: ~90 mg of iron
3. Maternal blood volume rises 45-50%: red cell mass also increases, but plasma rises more, producing 'physiological dilution'
4. Delivery blood loss: ~500 mL for vaginal delivery, ~1,000 mL for C-section
5. Lactation: breast milk is low in iron (~0.3 mg/L), but lactation delays return of menses, cutting period blood loss
WHO 2016 recommendations:
Routine 30-60 mg/day iron + 0.4 mg/day folate throughout pregnancyIron-deficient regions or anemia-endemic areas: daily supplementationIron-adequate or screening-normal regions: intermittent supplementation (3×/week) is also effective
The cost of pregnancy iron-deficiency anemia:
Maternal: fatigue, elevated risk of intrapartum and postpartum hemorrhageFetal: preterm birth, low birth weight, cognitive delay in infancy (iron is critical for infant myelination; long-term IQ averages 1-2 points lower — irreversible)The reverse is also a problem: maternal over-iron (Hb > 130 g/L) is linked to fetal growth restriction — not 'more is better'
Practical pitfalls of iron supplementation:
Form: ferrous sulfate / fumarate (Fe²⁺) > ferrous gluconate; polysaccharide-iron complexes are weaker; newer ferric maltol has fewer side effectsEmpty stomach gives the best absorption but more GI irritation; alternate-day dosing (Stoffel 2017) gives higher total absorption in healthy mildly-deficient individuals because daily dosing suppresses hepcidin (see iron / gut L4), and alternate days let hepcidin resetCo-administer with vitamin C: 50-100 mg vitamin C increases non-heme iron absorption 2-4× (see vitamin-c / iron L4)Avoid simultaneous calcium, tea, coffee, milk, or antacids — separate by at least 2 hoursSide effects: constipation, dark stools, GI upset; can halve the dose, switch forms, or, for persistent issues, consider IV ironSevere deficiency (Hb < 90 g/L) is hard to correct orally; usually directly treated with IV iron (ferric carboxymaltose)
On 'pregnancy tea / bird's nest / Ejiao for blood': Ejiao is traditionally said in TCM to 'tonify blood', but its actual iron content is very low (~0.2 mg/g dry); from a modern perspective, pork liver, beef, clams, and fortified grains contain 10-100× more iron than Ejiao.
Chapter 4
DHA · fetal brain
DHA · fetal brain
Fetal brain and retina go through a DHA-demand surge from mid-to-late pregnancy through the first 2 years postpartum: fetal gray matter (dry weight) is ~15-20% DHA, and the retina is ~50% DHA. All of this DHA must come from maternal blood — the fetus has very low ALA → DHA conversion capacity (< 1%).
ACOG / WHO / FAO recommendation (pregnancy + lactation): DHA + EPA ≥ 200-300 mg/day, achievable with 2-3 servings of low-mercury fish per week; DHA alone ≥ 200 mg/day is a stable target.
Fish is the best source, but mercury is a real concern. Per the FDA + EPA 2021 classification:
Best choices (2-3 servings/week, ~100 g each): cod, salmon, sardines, anchovies, trout, tilapia, haddock, Atlantic mackerel — these are low-mercury and high-DHA, ideal for pregnancyGood choices (1 serving/week): black sea bass, carp, Atlantic croaker, flounder, hakeAvoid (high mercury): shark, swordfish, bigeye tuna, tilefish (Gulf of Mexico), king mackerel, marlin, Atlantic orange roughy; limit canned tuna (especially albacore)
The mercury-vs-DHA balance: Hibbeln 2007 *Lancet* ALSPAC study followed 12,000 UK mother-baby pairs — children of mothers eating < 340 g/week (12 oz, the FDA's prior upper limit) had significantly lower verbal IQ. This challenged the older 'pregnant women should eat less fish' advice and led FDA to revise its 2014 / 2021 guidance to encourage fish rather than simply avoid it. The consensus: the DHA shortfall from not eating fish causes more harm than the mercury exposure from moderate intake of low-mercury fish.
Fish oil vs real fish:
Real fish > fish oil: also provides protein, selenium, iodine, vitamin D, and an intact lipid matrixFor pregnant women who don't eat fish: fish oil + algae-derived DHA is a reasonable substitute; algae DHA (vegan) is increasingly preferred, with zero mercuryInfant formulas now also add DHA + ARA; RCT evidence is mixed (Cochrane 2017 meta on cognitive and visual outcomes)
Marketing traps for 'pregnancy DHA gummies / high-concentration DHA':
Most DHA gummies have 200-250 mg/dose; eating fish twice a week already covers ~100%Ultra-high doses (1,000+ mg) provide no extra fetal benefit and raise bleeding risk at delivery (omega-3 inhibits platelets)'EPA boosts mood' and 'DHA makes your baby smarter' are over-marketed — the real evidence is for sufficiency, not megadosing
ACOG / WHO / FAO recommendation (pregnancy + lactation): DHA + EPA ≥ 200-300 mg/day, achievable with 2-3 servings of low-mercury fish per week; DHA alone ≥ 200 mg/day is a stable target.
Fish is the best source, but mercury is a real concern. Per the FDA + EPA 2021 classification:
Best choices (2-3 servings/week, ~100 g each): cod, salmon, sardines, anchovies, trout, tilapia, haddock, Atlantic mackerel — these are low-mercury and high-DHA, ideal for pregnancyGood choices (1 serving/week): black sea bass, carp, Atlantic croaker, flounder, hakeAvoid (high mercury): shark, swordfish, bigeye tuna, tilefish (Gulf of Mexico), king mackerel, marlin, Atlantic orange roughy; limit canned tuna (especially albacore)
The mercury-vs-DHA balance: Hibbeln 2007 *Lancet* ALSPAC study followed 12,000 UK mother-baby pairs — children of mothers eating < 340 g/week (12 oz, the FDA's prior upper limit) had significantly lower verbal IQ. This challenged the older 'pregnant women should eat less fish' advice and led FDA to revise its 2014 / 2021 guidance to encourage fish rather than simply avoid it. The consensus: the DHA shortfall from not eating fish causes more harm than the mercury exposure from moderate intake of low-mercury fish.
Fish oil vs real fish:
Real fish > fish oil: also provides protein, selenium, iodine, vitamin D, and an intact lipid matrixFor pregnant women who don't eat fish: fish oil + algae-derived DHA is a reasonable substitute; algae DHA (vegan) is increasingly preferred, with zero mercuryInfant formulas now also add DHA + ARA; RCT evidence is mixed (Cochrane 2017 meta on cognitive and visual outcomes)
Marketing traps for 'pregnancy DHA gummies / high-concentration DHA':
Most DHA gummies have 200-250 mg/dose; eating fish twice a week already covers ~100%Ultra-high doses (1,000+ mg) provide no extra fetal benefit and raise bleeding risk at delivery (omega-3 inhibits platelets)'EPA boosts mood' and 'DHA makes your baby smarter' are over-marketed — the real evidence is for sufficiency, not megadosing
Chapter 5
Menopause + male T
Menopause + male T
Female menopause (45-55) and male androgen decline (~1%/year from age 35) together form the most hormone-nutrition-dense stage of life.
Female menopause
The core change is the decline of ovarian function: post-menopausal estrogen drops ~90%, and progesterone also falls, triggering a cascade of downstream changes:
Accelerated bone loss — estrogen protects osteoblasts; after withdrawal, osteoclasts lose suppression and bone density can drop ~20% over 5-10 years (see calcium / bone-deposit L4)Rising cardiovascular risk — estrogen had been protecting the endothelium and LDLMetabolic-syndrome risk — visceral fat accumulation + insulin resistanceGenitourinary atrophy — vaginal dryness + recurrent urinary tract infectionsVasomotor symptoms — hot flashes, night sweats, insomnia (70-80% of women, average duration 7 years)Mood fluctuations + cognitive complaints — estrogen receptors are widely distributed in the brain
Evidence-based nutrition + lifestyle interventions:
Calcium 1,200 mg/day + vitamin D 800-1,000 IU + K2 100-180 μg/day: synergy on bone loss (see the calcium, vitamin-k2, vitamin-d stories)Resistance training 2-3×/week: stronger than any supplement at reducing bone lossSoy isoflavones: Cochrane 2013 shows 25-40% reduction in short-term hot flashes — weaker than HRT but with less long-term safety controversyLimit alcohol + quit smoking: both accelerate bone loss
The truth about HRT (hormone replacement therapy): the WHI 2002 (Rossouw, *JAMA*) large RCT caused HRT use to collapse, but the study population skewed older (mean age 63) — well past the menopause window. Modern consensus (NAMS 2022): for women within 10 years of menopause, < 60 years old, with moderate-to-severe symptoms, HRT's benefit exceeds its risk. Not 'lifelong contraindication' — it's a window-of-opportunity + individualization question.
Male androgen decline (some people call it andropause — not entirely accurate)
Total testosterone declines ~1%/year from age 35; by 65 the average cumulative drop is ~30%'Low T' ≠ 'symptomatic low T' — most older men's T decline is slow and many remain in the lower half of the normal range; symptoms often stem from obesity, low mood, and chronic disease rather than T itselfOnly true symptomatic primary or secondary hypogonadism has a medical indication for T replacement
Real nutrition / lifestyle levers for male T (by effect size):
1. Weight loss + strength training — going from BMI 30 to 25 raises total T 20-30% on average (Camacho 2013); the single strongest intervention
2. Sleep 7-8 hours — one week of sleep deprivation drops T 10-15%
3. Quit smoking + limit alcohol
4. Adequate zinc (see zinc story) — deficiency does lower T, but supplementing in already-replete men doesn't further raise it
5. Adequate vitamin D — some studies show benefit in deficient men; meta-analyses are weak
6. 'Natural T boosters' — D-aspartic acid, fenugreek, Tribulus, deer-horn velvet — mostly weak or unreplicated RCTs
'Male menopause supplements' is one of the most over-marketed product categories. The real levers for T are weight, sleep, exercise, and quitting — not supplements.
Female menopause
The core change is the decline of ovarian function: post-menopausal estrogen drops ~90%, and progesterone also falls, triggering a cascade of downstream changes:
Accelerated bone loss — estrogen protects osteoblasts; after withdrawal, osteoclasts lose suppression and bone density can drop ~20% over 5-10 years (see calcium / bone-deposit L4)Rising cardiovascular risk — estrogen had been protecting the endothelium and LDLMetabolic-syndrome risk — visceral fat accumulation + insulin resistanceGenitourinary atrophy — vaginal dryness + recurrent urinary tract infectionsVasomotor symptoms — hot flashes, night sweats, insomnia (70-80% of women, average duration 7 years)Mood fluctuations + cognitive complaints — estrogen receptors are widely distributed in the brain
Evidence-based nutrition + lifestyle interventions:
Calcium 1,200 mg/day + vitamin D 800-1,000 IU + K2 100-180 μg/day: synergy on bone loss (see the calcium, vitamin-k2, vitamin-d stories)Resistance training 2-3×/week: stronger than any supplement at reducing bone lossSoy isoflavones: Cochrane 2013 shows 25-40% reduction in short-term hot flashes — weaker than HRT but with less long-term safety controversyLimit alcohol + quit smoking: both accelerate bone loss
The truth about HRT (hormone replacement therapy): the WHI 2002 (Rossouw, *JAMA*) large RCT caused HRT use to collapse, but the study population skewed older (mean age 63) — well past the menopause window. Modern consensus (NAMS 2022): for women within 10 years of menopause, < 60 years old, with moderate-to-severe symptoms, HRT's benefit exceeds its risk. Not 'lifelong contraindication' — it's a window-of-opportunity + individualization question.
Male androgen decline (some people call it andropause — not entirely accurate)
Total testosterone declines ~1%/year from age 35; by 65 the average cumulative drop is ~30%'Low T' ≠ 'symptomatic low T' — most older men's T decline is slow and many remain in the lower half of the normal range; symptoms often stem from obesity, low mood, and chronic disease rather than T itselfOnly true symptomatic primary or secondary hypogonadism has a medical indication for T replacement
Real nutrition / lifestyle levers for male T (by effect size):
1. Weight loss + strength training — going from BMI 30 to 25 raises total T 20-30% on average (Camacho 2013); the single strongest intervention
2. Sleep 7-8 hours — one week of sleep deprivation drops T 10-15%
3. Quit smoking + limit alcohol
4. Adequate zinc (see zinc story) — deficiency does lower T, but supplementing in already-replete men doesn't further raise it
5. Adequate vitamin D — some studies show benefit in deficient men; meta-analyses are weak
6. 'Natural T boosters' — D-aspartic acid, fenugreek, Tribulus, deer-horn velvet — mostly weak or unreplicated RCTs
'Male menopause supplements' is one of the most over-marketed product categories. The real levers for T are weight, sleep, exercise, and quitting — not supplements.
Chapter 6
Fertility · the timeline you don't see
Fertility · the timeline you don't see
The physiological curve of fertility — the hard data Chinese-language society talks about least but should learn earliest.
Female natural conception probability (per menstrual cycle):
20-24 years: ~25-30%30 years: ~20%35 years: ~15%38 years: ~10%40 years: ~5%42 years: ~3%45 years: < 2%
The underlying cause: women are born with ~1-2 million oocytes; by puberty this drops to ~300,000; each menstrual cycle consumes ~1,000 (only 1 ovulates; the rest undergo apoptosis). By age 40, ~20-30 thousand remain — and the issue isn't just quantity: the chromosomal aneuploidy rate rises from < 10% at 30 to ~50% at 40, which is the chemical root of the rising miscarriage and Down syndrome risks with maternal age.
Male fertility decline is gentler but equally real:
After age 35, sperm DNA fragmentation risesDe novo mutation rate rises (paternal-age contribution); paternal age > 45 is mildly associated with autism + schizophrenia risk in offspringBut men can still conceive at age 70 — the quantity curve is far flatter than the female curve
The reality of assisted reproductive technology (ART):
IVF (in-vitro fertilization) single-cycle live-birth rate:
< 35 years: ~35-40%35-37 years: ~30%38-40 years: ~20%41-42 years: ~10%> 42 years (own eggs): ~3-5%
'ART compensates for age' is a common misconception. ART improves per-cycle efficiency but cannot reverse oocyte-quality decline. Egg freezing (social) is best before age 34; after 38, both retrieved egg count and downstream IVF success rates drop significantly. PGT-A (preimplantation genetic testing for aneuploidies) improves per-transfer success rates, but doesn't create good embryos out of thin air.
Practical principles (a regret-reducing checklist):
If you want children, do at least one fertility assessment before age 30 (AMH + baseline antral follicle count) — not as pressure, but as decision information< 35 and trying to conceive: if 6 months of attempts haven't worked, see an infertility clinic (the standard is 1 year, shortened to 6 months for 35+)Uncertain when to have children: consult reproductive endocrinology about egg freezing; deciding early beats deciding lateMen 35-45: also worth a semen analysis + DNA fragmentation test — it isn't only 'the woman's issue'Chronic disease or long-term medication: consult on pregnancy risks beforehand
Social-level facts:
The costs of late childbearing: infertility-treatment financial burden, chromosomal-abnormality risk, advanced-age pregnancy complicationsThe costs of early childbearing: career, finances, marital readinessThere is no 'right age', but transparent information lets people choose actively rather than learn only in retrospect
The core message of this scene: the 'biological clock' isn't patriarchal anxiety talk — it's real chemistry. But it isn't destiny either; early knowledge + early assessment + early decision expand the range of choices within biological constraints.
Female natural conception probability (per menstrual cycle):
20-24 years: ~25-30%30 years: ~20%35 years: ~15%38 years: ~10%40 years: ~5%42 years: ~3%45 years: < 2%
The underlying cause: women are born with ~1-2 million oocytes; by puberty this drops to ~300,000; each menstrual cycle consumes ~1,000 (only 1 ovulates; the rest undergo apoptosis). By age 40, ~20-30 thousand remain — and the issue isn't just quantity: the chromosomal aneuploidy rate rises from < 10% at 30 to ~50% at 40, which is the chemical root of the rising miscarriage and Down syndrome risks with maternal age.
Male fertility decline is gentler but equally real:
After age 35, sperm DNA fragmentation risesDe novo mutation rate rises (paternal-age contribution); paternal age > 45 is mildly associated with autism + schizophrenia risk in offspringBut men can still conceive at age 70 — the quantity curve is far flatter than the female curve
The reality of assisted reproductive technology (ART):
IVF (in-vitro fertilization) single-cycle live-birth rate:
< 35 years: ~35-40%35-37 years: ~30%38-40 years: ~20%41-42 years: ~10%> 42 years (own eggs): ~3-5%
'ART compensates for age' is a common misconception. ART improves per-cycle efficiency but cannot reverse oocyte-quality decline. Egg freezing (social) is best before age 34; after 38, both retrieved egg count and downstream IVF success rates drop significantly. PGT-A (preimplantation genetic testing for aneuploidies) improves per-transfer success rates, but doesn't create good embryos out of thin air.
Practical principles (a regret-reducing checklist):
If you want children, do at least one fertility assessment before age 30 (AMH + baseline antral follicle count) — not as pressure, but as decision information< 35 and trying to conceive: if 6 months of attempts haven't worked, see an infertility clinic (the standard is 1 year, shortened to 6 months for 35+)Uncertain when to have children: consult reproductive endocrinology about egg freezing; deciding early beats deciding lateMen 35-45: also worth a semen analysis + DNA fragmentation test — it isn't only 'the woman's issue'Chronic disease or long-term medication: consult on pregnancy risks beforehand
Social-level facts:
The costs of late childbearing: infertility-treatment financial burden, chromosomal-abnormality risk, advanced-age pregnancy complicationsThe costs of early childbearing: career, finances, marital readinessThere is no 'right age', but transparent information lets people choose actively rather than learn only in retrospect
The core message of this scene: the 'biological clock' isn't patriarchal anxiety talk — it's real chemistry. But it isn't destiny either; early knowledge + early assessment + early decision expand the range of choices within biological constraints.